Dr. Teresita Rodríguez Obaya
The pioneering scientist behind NeuralCIM, dedicated to bringing hope to families affected by neurodegenerative diseases.
A Lifetime Dedicated to Healing
Dr. Teresita Rodríguez Obaya is a renowned Cuban biotechnology scientist who has dedicated her career to finding treatments for neurodegenerative diseases. As the founder of Cuba's Centre of Molecular Immunology (CIM), she has led groundbreaking research that has brought new hope to families around the world.
Her Journey to Discovery
Dr. Obaya's path to developing NeuralCIM spans decades of research, perseverance, and unwavering commitment to patients.
Early Research
Dr. Obaya began her research focusing on neurodegenerative diseases, recognizing the urgent need for effective treatments for conditions like Parkinson's disease and Alzheimer's.
Founding CIM
She founded Cuba's Centre of Molecular Immunology (CIM), establishing a world-class biotechnology research facility that would become the birthplace of NeuralCIM.
Developing NeuralCIM
Through years of research, Dr. Obaya developed NeuralCIM (NeuroEPO), a variant of EPO that shows remarkable promise in treating neurodegenerative diseases without hematopoietic effects.
Clinical Success
Clinical trials demonstrated that NeuralCIM significantly delays and sometimes halts Alzheimer's disease progression, offering new hope where none existed before.
Triumph Over the U.S. Blockade
Dr. Obaya's work has been carried out under extraordinarily challenging circumstances. The decades-long U.S. blockade against Cuba has made it incredibly difficult to obtain the supplies and materials needed for biotechnology research.
Despite these obstacles—which prevent supplies with more than 10% U.S. content from reaching Cuba and effectively cut the island off from most global resources—Dr. Obaya and her team persevered. Their dedication has made NeuralCIM available to patients from around the world.
"Teresita's Dream: Cuba's Battle Against Alzheimer's"
— Documentary by Belly of the Beast
Research Focus & Achievements
Dr. Obaya originally developed NeuralCIM to treat multiple neurological conditions, with remarkable results.
Parkinson's Disease
Original development target for NeuralCIM, showing significant improvement in motor function and quality of life for patients.
Stroke Recovery
Research demonstrated NeuralCIM's potential in supporting neurological recovery following cerebrovascular events.
Alzheimer's Disease
Most recent breakthrough showing that NeuralCIM significantly delays and sometimes halts Alzheimer's progression.
"Teresita's Dream: Cuba's Battle Against Alzheimer's"
This powerful documentary by Belly of the Beast chronicles the third phase of efficacy studies for NeuralCIM and tells the remarkable story behind this breakthrough treatment. The film captures both the scientific achievement and the human determination that made it possible.
Viewers witness firsthand the challenges faced by Cuban scientists working under the U.S. blockade, and the hope that NeuralCIM brings to families affected by Alzheimer's disease.
Watch Documentary
A Legacy of Hope
Dr. Obaya's work continues to transform lives and offer hope where none existed before.
Scientific Excellence
World-renowned biotechnology research with rigorous clinical validation
Patient-Centered
Every development decision made with patient wellbeing as the priority
Global Impact
Treatment now available to patients from around the world
Experience Dr. Obaya's Vision
Learn more about NeuralCIM treatment and how Dr. Obaya's groundbreaking research could help your family. Schedule a free consultation with our team.